0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Image of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Grace S. Rozycki, MD

More Author Information
Arch Surg. 2007;142(1):96. doi:10.1001/archsurg.142.1.96.
Text Size: A A A
Published online

Histopathological findings showed the mass to be a well-differentiated, pedunculated hepatocellular carcinoma (HCC) with regions of necrosis and cystic degeneration. On immunohistochemical analysis, the tumor stained positively for alpha fetoprotein. Excision was complete, with a clear margin of 11 mm within the pedicle.

Pedunculated HCC can be defined as carcinoma protruding from the liver with or without a pedicle and was first described by Roux in 1897.1It is a rare variant of HCC; more frequently occurring variants are classified as nodular, massive, and diffuse.2Pedunculated tumors do not differ significantly from HCCs in terms of patient demographics, viral infection, or associated liver disease.3It has been proposed to subclassify the macroscopic appearances of pedunculated HCC into pedunculated type with a pedicle (subtype I, as is this case) and pedunculated type without a pedicle and attached to the liver surface (subtype II).4

In Japan, pedunculated HCC represents 0.24% to 3.00% of all cases of HCC.5In the largest published series to date, Yeh et al3found that 18 (4.2%) of 432 patients with HCC had pedunculated growth. Of the pedunculated HCC group, 11 patients (61%) had well-differentiated histological characteristics and a significantly improved overall survival. The mean survival in the pedunculated group was 94 months, compared with 54.5 months for nonpedunculated HCCs. The pedunculated tumors tended to be larger and to have a more prominent capsule. Although increased tumor size is associated with poorer prognosis in HCC,6a wider resection margin was obtained with pedunculated tumors despite a tendency for larger tumor size. Yeh et al3suggest that pedunculated tumors protrude from a pedicle; thus, growth into the liver is limited. Most importantly, the pedunculated tumors exhibited less vascular invasion than did the nonpedunculated HCCs. Vascular invasion is widely accepted as the most consistently reported risk factor for recurrence after resection,7which likely explains the improved survival seen in patients with pedunculated HCC in that series.

Corresponding Author:Lucy Tzouliadis, MBChB, MRCS, Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke RG24 9NA, England (ltzouliadis@hotmail.com).

Accepted for Publication:December 18, 2005.

Author Contributions:Study concept and design: Tzouliadis, Hulin, Shaw, and Rees. Acquisition of data: Tzouliadis. Analysis and interpretation of data: Rees. Drafting of the manuscript: Tzouliadis and Shaw. Critical revision of the manuscript for important intellectual content: Tzouliadis, Hulin, Shaw, and Rees. Administrative, technical, and material support: Tzouliadis and Hulin. Study supervision: Tzouliadis, Hulin, Shaw, and Rees.

Financial Disclosure:None reported.

Roux  C Un cas de cancer primitive du foie avec pericholecystite calculeuse, perforation intestinale: hemostase hepatigue. Rev Med Suisse Romande 1897;17114- 119
Eggel  H Uber das primare Carcinom der Leber. Betir Pathol Anat Allg Pathol 1901;30506- 604
Yeh  CNLee  WCJeng  LBChen  MF Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg 2002;261133- 1138
PubMed Link to Article
Nakashima  TOkuda  KKojiro  M  et al.  Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer 1983;51863- 877
PubMed Link to Article
Horie  YKatoh  SYoshida  HImaoka  TSuou  THirayama  C Pedunculated hepatocellular carcinoma: report of three cases and review of literature. Cancer 1983;51746- 751
PubMed Link to Article
Chen  MFJeng  LB Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12S329- S334
PubMed Link to Article
Yamamoto  JKosuge  TTakayama  T  et al.  Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;831219- 1222
PubMed Link to Article

Figures

Tables

References

Roux  C Un cas de cancer primitive du foie avec pericholecystite calculeuse, perforation intestinale: hemostase hepatigue. Rev Med Suisse Romande 1897;17114- 119
Eggel  H Uber das primare Carcinom der Leber. Betir Pathol Anat Allg Pathol 1901;30506- 604
Yeh  CNLee  WCJeng  LBChen  MF Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg 2002;261133- 1138
PubMed Link to Article
Nakashima  TOkuda  KKojiro  M  et al.  Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer 1983;51863- 877
PubMed Link to Article
Horie  YKatoh  SYoshida  HImaoka  TSuou  THirayama  C Pedunculated hepatocellular carcinoma: report of three cases and review of literature. Cancer 1983;51746- 751
PubMed Link to Article
Chen  MFJeng  LB Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12S329- S334
PubMed Link to Article
Yamamoto  JKosuge  TTakayama  T  et al.  Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;831219- 1222
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com

Care at the Close of Life EDUCATION GUIDES
Integrating Palliative Care for Liver Transplant Candidates